In contrast, upregulated NT5DC2 expression was associated with favorable OS and RFS in patients with PAAD, and upregulated NT5C2 expression was associated with poor RFS in patients with PAAD with B cell enrichment (Figure 7B-D). This evidence concerns the gene NT5C2 and pancreatic adenocarcinoma.